Home/Filings/4/0001104659-20-113577
4//SEC Filing

Englese Thomas 4

Accession 0001104659-20-113577

CIK 0001708527other

Filed

Oct 7, 8:00 PM ET

Accepted

Oct 8, 8:27 PM ET

Size

7.9 KB

Accession

0001104659-20-113577

Insider Transaction Report

Form 4
Period: 2020-10-07
Englese Thomas
Chief Commercial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-10-07+33,48833,488 total
    Exercise: $17.00Exp: 2030-10-06Class A Common Stock (33,488 underlying)
  • Award

    Restricted Stock Units

    2020-10-07+13,89013,890 total
    Class A Common Stock (13,890 underlying)
Footnotes (3)
  • [F1]This option vests and becomes exercisable in 4 substantially equal annual installments on each of the successive years following October 7, 2020.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock.
  • [F3]The restricted stock units will vest in full on October 7, 2023 and do not have an expiration date.

Documents

1 file

Issuer

AZIYO BIOLOGICS, INC.

CIK 0001708527

Entity typeother

Related Parties

1
  • filerCIK 0001825799

Filing Metadata

Form type
4
Filed
Oct 7, 8:00 PM ET
Accepted
Oct 8, 8:27 PM ET
Size
7.9 KB